Published in Antimicrob Agents Chemother on March 01, 1980
Properties of novel beta-lactamase produced by Bacteroides fragilis. Antimicrob Agents Chemother (1983) 3.59
Improved Listeria monocytogenes selective agar. Appl Environ Microbiol (1986) 3.33
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance. Antimicrob Agents Chemother (1981) 2.96
Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli. Antimicrob Agents Chemother (1981) 1.61
Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum. Antimicrob Agents Chemother (1986) 1.57
In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin. Antimicrob Agents Chemother (1984) 1.50
Penetration of moxalactam into its target proteins in Escherichia coli K-12: comparison of a highly moxalactam resistant mutant with its parent strain. Antimicrob Agents Chemother (1981) 1.29
Effect of moxalactam on human fecal microflora. Antimicrob Agents Chemother (1986) 1.19
In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models. Antimicrob Agents Chemother (2003) 1.05
Effect of probenecid on the pharmacokinetics of moxalactam. Antimicrob Agents Chemother (1982) 1.04
Determination of moxalactam in human body fluids by liquid chromatographic and microbiological methods. Antimicrob Agents Chemother (1981) 1.02
Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults. Antimicrob Agents Chemother (1982) 0.95
Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli. Antimicrob Agents Chemother (1981) 0.95
Covalent binding of moxalactam to cephalosporinase of Citrobacter freundii. Antimicrob Agents Chemother (1985) 0.95
Renal disposition of moxalactam in experimental animals as revealed by stop-flow analysis. Antimicrob Agents Chemother (1983) 0.94
Cephamycin inactivation due to enzymatic hydrolysis by beta-lactamase from Bacteroides fragilis. Antimicrob Agents Chemother (1985) 0.92
Penetration of cephalosporins and corresponding 1-oxacephalosporins through the outer layer of Gram-negative bacteria and its contribution to antibacterial activity. Antimicrob Agents Chemother (1982) 0.84
Role of the 7 alpha-methoxy and side-chain carboxyl of moxalactam in beta-lactamase stability and antibacterial activity. Antimicrob Agents Chemother (1981) 0.84
Moxalactam pharmacokinetics in children. Antimicrob Agents Chemother (1982) 0.80
Inhibition of the rate of 14CO2 production from [14C]ethanol in rats given beta-lactam antibiotics with disulfiram-like effects. Antimicrob Agents Chemother (1985) 0.75
7 alpha-formylamino substituent confers beta-lactamase-inactivating potency on 1-oxacephalosporins. Antimicrob Agents Chemother (1986) 0.75
The beta-lactamases of gram-negative bacteria and their possible physiological role. Adv Microb Physiol (1973) 25.78
The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics. J Antimicrob Chemother (1976) 18.58
Cefuroxime, a new cephalosporin antibiotic: activity in vitro. Antimicrob Agents Chemother (1976) 10.56
Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases. Antimicrob Agents Chemother (1974) 9.66
Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation. Antimicrob Agents Chemother (1974) 8.84
beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin. Antimicrob Agents Chemother (1978) 8.28
In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin. Antimicrob Agents Chemother (1977) 7.35
Pharmacokinetics of cefazolin compared with four other cephalosporins. J Infect Dis (1973) 3.91
A DIRECT SPECTROPHOTOMETRIC ASSAY FOR PENICILLIN BETA-LACTAMASE (PENICILLINASE). Biochim Biophys Acta (1965) 2.34
Bacteroides fragilis and HR 756. J Antimicrob Chemother (1979) 1.73
Comparative serum levels and protective activity of parenterally administered cephalosporins in experimental animals. Antimicrob Agents Chemother (1974) 1.09
Biological and chemotherapeutic studies on three semisynthetic cephamycins. J Antibiot (Tokyo) (1978) 0.90
Beta-lactamases. Int J Clin Pharmacol Biopharm (1979) 0.89
A compendium of gene expression in normal human tissues. Physiol Genomics (2001) 5.66
Transcriptional sequencing: A method for DNA sequencing using RNA polymerase. Proc Natl Acad Sci U S A (1998) 3.78
Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med (1998) 3.62
Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother (1979) 3.51
Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology (1992) 3.40
In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic. Antimicrob Agents Chemother (1984) 3.35
Production of low-affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1987) 3.07
CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med (2001) 3.05
cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc Natl Acad Sci U S A (1987) 2.97
Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron (2001) 2.94
The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol Cell Biol (2001) 2.87
The production of migration inhibition factor by B and T cells of the guinea pig. J Exp Med (1973) 2.86
Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol (1999) 2.81
Brain dynein (MAP1C) localizes on both anterogradely and retrogradely transported membranous organelles in vivo. J Cell Biol (1990) 2.76
In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother (2000) 2.73
A Flavobacterium sp. that degrades diazinon and parathion. Can J Microbiol (1973) 2.72
The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J (1997) 2.71
Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology (2000) 2.61
Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology (1983) 2.53
Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci U S A (1999) 2.53
Molecular analysis of the Escherichia coli hns gene encoding a DNA-binding protein, which preferentially recognizes curved DNA sequences. Mol Gen Genet (1991) 2.50
Determination of antibody-hapten equilibrium constants by an ammonium sulfate precipitation technique. J Immunol (1969) 2.49
Quantitative measurements of proton motive force and motility in Bacillus subtilis. J Bacteriol (1980) 2.38
A familial factor XIII subunit B deficiency. Br J Haematol (1990) 2.23
Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci U S A (1985) 2.18
Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med (1997) 2.17
Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest (2001) 2.15
Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration. J Antibiot (Tokyo) (1970) 2.15
In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin. Antimicrob Agents Chemother (1988) 2.08
Rho-kinase/ROCK is involved in cytokinesis through the phosphorylation of myosin light chain and not ezrin/radixin/moesin proteins at the cleavage furrow. Oncogene (2000) 2.08
Nucleotide sequence of the Serratia marcescens SR50 chromosomal ampC beta-lactamase gene. FEMS Microbiol Lett (1990) 2.04
Acute renal failure associated with spontaneous perinephric hemorrhage. Nephron (2000) 2.02
Occlusive thromboaortopathy (Takayasu's disease) and pregnancy. Clinical course and management of 33 pregnancies and deliveries. Am J Cardiol (1982) 2.00
Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene (1988) 1.99
K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci U S A (1990) 1.99
Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis. J Bacteriol (1995) 1.97
In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative. Antimicrob Agents Chemother (Bethesda) (1969) 1.96
Two distinct mechanisms cause heterogeneity of 16S rRNA. J Bacteriol (1999) 1.94
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis. Antimicrob Agents Chemother (2000) 1.93
Nucleotide-induced stable complex formation by HIV-1 reverse transcriptase. Biochemistry (1997) 1.82
Membrane (M) protein of HVJ (Sendai virus): its role in virus assembly. Virology (1976) 1.81
Crystal structure of rat biliverdin reductase. Nat Struct Biol (2001) 1.77
Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol (1996) 1.77
Phosphatase activity of histidine kinase EnvZ without kinase catalytic domain. Proc Natl Acad Sci U S A (2000) 1.75
The transfer region of IncI1 plasmid R64: similarities between R64 tra and legionella icm/dot genes. Mol Microbiol (2000) 1.74
Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem (1996) 1.74
Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene (2006) 1.73
Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci U S A (1986) 1.71
Systematic mutational analysis revealing the functional domain organization of Escherichia coli nucleoid protein H-NS. J Mol Biol (1996) 1.70
Activity of migration inhibitory factor in the absence of antigen. J Immunol (1972) 1.68
Drug-sensitivity of El Tor vibrio strains isolated in the Philippines in 1964 and 1965. Bull World Health Organ (1967) 1.67
Synthesis and alpha-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents. J Med Chem (1986) 1.67
Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol (2003) 1.66
Molecular cloning of a human Ca2+-dependent cell-cell adhesion molecule homologous to mouse placental cadherin: its low expression in human placental tissues. J Cell Biol (1989) 1.66
Adaptive rundown of excitatory post-synaptic potentials at synapses between hair cells and eight nerve fibres in the goldfish. J Physiol (1978) 1.66
Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol (1999) 1.66
Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem (2000) 1.65
LPP expression during in vitro smooth muscle differentiation and stent-induced vascular injury. Circ Res (2006) 1.65
Genetic behavior of R factors in Vibrio cholerae. J Bacteriol (1972) 1.64
Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells (1998) 1.62
Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase. Antimicrob Agents Chemother (1979) 1.61
Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic beta 3-adrenergic agonist. J Clin Invest (1996) 1.59
Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J Virol (1997) 1.58
Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J Biol Chem (2000) 1.57
Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J (1978) 1.55
Polyhydroxylated alkaloids isolated from mulberry trees (Morusalba L.) and silkworms (Bombyx mori L.). J Agric Food Chem (2001) 1.55
Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics. J Antibiot (Tokyo) (1979) 1.54
The behavior of oxonol dyes in phospholipid dispersions. Biophys J (1979) 1.53
Sequence specificity of furin, a proprotein-processing endoprotease, for the hemagglutinin of a virulent avian influenza virus. J Virol (1994) 1.52
Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am J Pathol (1998) 1.52
Purification and characterization of the Rieske iron-sulfur protein from Thermus thermophilus. Evidence for a [2Fe-2S] cluster having non-cysteine ligands. J Biol Chem (1984) 1.51
Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat. Eur J Endocrinol (1997) 1.50
Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas/carcinomas which showed a point mutation in the APC gene. Intern Med (1997) 1.50
Outbreak of Chinese herb nephropathy in Japan: are there any differences from Belgium? Intern Med (2001) 1.50
Developmental expression of the mouse gene coding for the Krüppel-like transcription factor KLF5. Dev Dyn (2000) 1.50
Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol (1998) 1.49
Multiple bosonic mode coupling in the electron self-energy of (La2-xSrx)CuO4. Phys Rev Lett (2005) 1.49
A new agglutination test for serum antibodies to adult T-cell leukemia virus. Gan (1984) 1.48
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis. Antimicrob Agents Chemother (2000) 1.48
Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke (1988) 1.48
Diagnostic hand anomalies in Smith-Magenis syndrome: four new patients with del (17)(p11.2p11.2) Am J Med Genet (1991) 1.48
A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res (1993) 1.47
In vitro synthesis and posttranslational uptake of cytochrome c into isolated mitochondria: role of a specific addressing signal in the apocytochrome. Proc Natl Acad Sci U S A (1981) 1.47
Cytodifferentiation of atypical adenomatous hyperplasia and bronchioloalveolar lung carcinoma: immunohistochemical and ultrastructural studies. Virchows Arch (1997) 1.47
DNA rearrangement of the shufflon determines recipient specificity in liquid mating of IncI1 plasmid R64. J Mol Biol (1994) 1.47
Cushing's syndrome due to primary adrenocortical nodular dysplasia, cardiac myxomas, and spotty pigmentation, complicated by sarcoidosis. Intern Med (1992) 1.46
Argyrophilic proteins of the nucleolar organizer region in acute leukemias and its relation to the S-phase fraction of leukemic cells. Acta Haematol (1992) 1.46
Human NRAMP2/DMT1, which mediates iron transport across endosomal membranes, is localized to late endosomes and lysosomes in HEp-2 cells. J Biol Chem (2000) 1.46
Slime production by Pseudomonas aeruginosa. II. A new synthetic medium and cultural conditions suitable for slime production by Pseudomonas aeruginosa. Jpn J Microbiol (1973) 1.45
Oriental orchid (Cymbidium pumilum) attracts drones of the Japanese honeybee (Apis cerana japonica) as pollinators. Experientia (1991) 1.44
Simple procedure of DNA isolation from human serum. Nucleic Acids Res (1991) 1.44
Four-Step endoscopic esophageal mucosal resection (EEMR) tube method of resection for early esophageal cancer. Endoscopy (2004) 1.44
Use of lipophilic cation-permeable mutants for measurement of transmembrane electrical potential in metabolizing cells of Escherichia coli. J Bacteriol (1981) 1.43
The forkhead-associated domain of NBS1 is essential for nuclear foci formation after irradiation but not essential for hRAD50[middle dot]hMRE11[middle dot]NBS1 complex DNA repair activity. J Biol Chem (2001) 1.43
Mutations of a novel human RAD54 homologue, RAD54B, in primary cancer. Oncogene (1999) 1.43
Expression and localization of the water channels in human autosomal dominant polycystic kidney disease. Nephron (1997) 1.43
Systemic hypotensive response to protamine following chronic inhibition of nitric oxide synthase in rats. Can J Anaesth (1998) 1.43
Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res (1991) 1.43
Purification and properties of heme oxygenase from pig spleen microsomes. J Biol Chem (1978) 1.42